Cost-effectiveness analysis of SBRT versus IMRT for low-risk prostate cancer

David J. Sher, Ravi B. Parikh, Shawnda Mays-Jackson, Rinaa S. Punglia

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint Dive into the research topics of 'Cost-effectiveness analysis of SBRT versus IMRT for low-risk prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences